Ustekinumab

Ustekinumab is a high-purity Active Pharmaceutical Ingredient supplied by Mediocon Inc conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India.

Ustekinumab is a fully human monoclonal antibody (IgG1κ) that binds to the p40 subunit shared by interleukins IL-12 and IL-23, blocking their interaction with IL-12Rβ1. It is approved for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Plaque psoriasis treatment
• Psoriatic arthritis management
• Crohn's disease therapy
• Ulcerative colitis treatment

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings